NGM Biopharmaceuticals Lands $20,710,000 Series D Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=539ddb0d-44d9-46e0-8a1e-8a1fb1fe190b
Date
2/24/2015
Company Name
NGM Biopharmaceuticals
Mailing Address
630 Gateway Blvd South San Francisco, CA 94080 USA
Company Description
NGM is a privately-held drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity, muscle wasting and other cardiometabolic diseases.
Website
http://www.ngmbio.com
Transaction Type
Venture Equity
Transaction Amount
$20,710,000
Transaction Round
Series D
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor